Annual report pursuant to Section 13 and 15(d)

Segment Reporting (Tables)

v3.24.0.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The tables below present financial information for the Company’s two operating business segments.
Year Ended December 31,
2023 2022
Revenues:
Corporate clinics $ 70,718,880  $ 59,422,294 
Franchise operations 46,977,476  41,830,016 
Total revenues
$ 117,696,356  $ 101,252,310 
Depreciation and amortization:
Corporate clinics $ 7,415,395  $ 5,557,494 
Franchise operations 809,135  744,172 
Corporate administration 357,673  344,956 
Total depreciation and amortization $ 8,582,203  $ 6,646,622 
Segment operating (loss) income:
Corporate clinics $ (2,502,643) $ 110,257 
Franchise operations 20,332,354  17,340,402 
Unallocated corporate (19,902,798) (16,622,405)
Total segment operating (loss) income $ (2,073,087) $ 828,254 
Reconciliation of total segment operating (loss) income to consolidated earnings before income taxes:
Total segment operating (loss) income $ (2,073,087) $ 828,254 
Other income (expense), net 3,711,843  (133,101)
Income before income tax expense $ 1,638,756  $ 695,153 
Schedule of Reconciliation of Assets from Segment to Consolidated
December 31, 2023 December 31, 2022
Segment assets:
Corporate clinics $ 52,210,617  $ 56,008,234 
Franchise operations 10,521,582  12,360,878 
Total segment assets $ 62,732,199  $ 68,369,112 
Unallocated cash and cash equivalents and restricted cash $ 19,214,292  $ 10,550,417 
Unallocated property and equipment 2,843,491  915,216 
Other unallocated assets 2,360,877  13,655,632 
Total assets $ 87,150,859  $ 93,490,377